Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning
announced further results from its recently completed second-generation study
in 40 rats in addition to the partial results released earlier this month. The
in vivo study evaluated the ability of the company’s DehydraTECH™ technology to
deliver nicotine as quickly as 2 minutes after oral administration. Lexaria’s
technology delivered 90.2% more nicotine over the first 10 minutes of the study
than the concentration-matched control formulation by the 10-minute mark. To
better commercialize opportunities within the nicotine sector, the company has
also completed the formation of a wholly-owned subsidiary, Lexaria Nicotine
Corp. “Lexaria’s DehydraTECH™ delivery technology continues to demonstrate its
superior effectiveness in delivering nicotine without the need for combustion
or the need for inhalation whatsoever,” Lexaria Bioscience Corp CEO Chris Bunka
stated in the news release. “Crossing the blood brain barrier is a significant
achievement all on its own and this data confirms the outcome of our earlier
first-generation test.”
To view the full press release, visit http://ibn.fm/hlv1J
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment